Form 4: Abbott Laboratories Vice President John A. McCoy, Jr. Reports Stock Transactions

Abbott Laboratories' Vice President, John A. McCoy, Jr., reports the disposition and acquisition of company stock, including sales to cover tax obligations.

Summary

• John A. McCoy, Jr., a Vice President at Abbott Laboratories, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• On February 29, 2024, 921 common shares were disposed of to cover tax obligations at a price of $120.05 per share.
• On March 1, 2024, 472 common shares were sold at a price of $118.5 per share.
• Following these transactions, McCoy directly owns 18,760 common shares and indirectly owns 56 shares through a Profit Sharing Trust as of March 1, 2024.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders, providing transparency into their trading activities. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the actions of company leadership.

Key Dates